Search

Special train fare discount

Discounts of up to 75% on Trenitalia train journeys for EHA2025 delegates.

Read more

Target audience

You are a hematologist working at an academic center or a large community hospital that is known for running clinical trials.

Read more

EBAH Certified Meetings

In this page, you will find hematology-related meetings which are either EBAH-certified or from partners of EHA. You can choose to see meetings per year or category in the menus below.

Read more

Travel Grants

Travel grant application is now closed. Travel grants are intended to support young investigators to participate in the 7th European CAR T-cell Meeting; therefore, applicants should be 40 years of age or younger.

Read more

How can I start contributing?

Getting started is easy! Here are a few good-to-know tips, that will help you navigate the different aspects of the EHA Hub.

Read more

EHA Congratulates EHA Research Grants 2022 Recipients

The Hague, May 30, 2022 – EHA congratulates eight talented researchers in hematology on their receipt of the EHA Research Grants 2022 after a rigorous selection process.

Read more

Registration

Register closed

Registration fee includes:

Access to all scientific and educational sessions of the meeting
Networking opportunities during breaks 
Coffee breaks on October 18-20 and lunch on October 19

All fees include VAT.

Read more

Special airfare discount

A 10% discount on Air France or KLM airfares for EHA2025 attendees. If you'll be flying to EHA2025, you can benefit from a special discount courtesy of Air France-KLM Global Meetings & Events.

Read more

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression, with benefits sustained at two years

ELOQUENT-2, which evaluated elotuzumab in combination with lenalidomide and dexamethasone, is the first Phase III study to demonstrate the benefit of directly activating the immune system in the treatment of patients with relapsed or refractory multiple myeloma.

Read more